MarketPulse
I

$IRMD

2 articles found
2 positive
0 negative
0 neutral
The Motley FoolThe Motley Fool··Robert Izquierdo

Iradimed CEO Dumps $694K in Stock—Here's Why Investors Shouldn't Panic

Iradimed CEO sells $694K in shares via pre-planned strategy while retaining 4M+ shares. Strong 78% stock gain reflects 14% revenue growth, but 42x forward P/E suggests patience before buying.
IRMDstock valuationearnings growth
GlobeNewswire Inc.GlobeNewswire Inc.··Na

IRADIMED to Present MRI Device Innovation at Roth Conference as Medical Device Market Heats Up

IRADIMED Corporation to present MRI-compatible medical device portfolio at prestigious Roth Conference in March 2026, with CEO and CFO meeting investors directly.
IRMDinvestor conferencemedical technology